Breaking News Instant updates and real-time market news.

SCYX

SCYNEXIS

$4.80

0.31 (6.90%)

, SLRC

Solar Capital

$20.50

0.11 (0.54%)

16:19
10/05/16
10/05
16:19
10/05/16
16:19

SCYNEXIS announces complete results from two Phase 2 studies

Drug development company SCYNEXIS (SCYX) announced the complete results of its two recently completed Phase 2 studies as well as the closing of a $15M term loan with Solar Capital Ltd. (SLRC). In the first study, treatment with oral SCY-078 in patients with vulvovaginal candidiasis, resulted in significantly better clinical cure rates and fewer recurrences of VVC at the four-month follow-up when compared to the standard of care. In the second study, which evaluated oral SCY-078 as a step down therapy in patients with invasive candidiasis, oral SCY-078 achieved the target exposure for efficacy and was well-tolerated.

SCYX

SCYNEXIS

$4.80

0.31 (6.90%)

SLRC

Solar Capital

$20.50

0.11 (0.54%)

  • 03

    Nov

SCYX SCYNEXIS
$4.80

0.31 (6.90%)

08/09/16
WBBS
08/09/16
UPGRADE
Target $8
WBBS
Buy
SCYNEXIS upgraded to Buy from Hold at WBB Securities
WBB Securities upgraded SCYNEXIS to Buy with an $8 price target.
08/17/16
GUGG
08/17/16
INITIATION
Target $15
GUGG
Buy
SCYNEXIS initiated with a Buy at Guggenheim
Target $15.
08/17/16
08/17/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. HP Enterprise (HPE) initiated with a Market Perform at Raymond James. 2. SCYNEXIS (SCYX) initiated with a Buy at Guggenheim. 3. Garmin (GRMN) initiated with a Neutral at Longbow. 4. MediWound (MDWD) initiated with an Outperform at Wells Fargo. 5. Enerplus (ERF) initiated with a Buy at Canaccord. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/03/16
BMUR
10/03/16
INITIATION
Target $16
BMUR
Buy
SCYNEXIS coverage assumed with a Buy at Brean Capital
Brean Capital analyst Defei Yang assumed coverage on SCYNEXIS with a Buy citing the Q4 meeting with the FDA for its lead candidate and several upcoming catalysts for its drugs in trial. Yang has a $16 price target on SCYNEXIS shares.
SLRC Solar Capital
$20.50

0.11 (0.54%)

04/28/16
DBAB
04/28/16
DOWNGRADE
Target $7
DBAB
Hold
Prospect Capital downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Stephen Laws downgraded Prospect Capital (PSEC) to Hold citing valuation after lowering his price target for the shares to $7 from $8.50. The analyst views other Business Development Companies as more attractive, with his favorite being Solar Capital (SLRC).

TODAY'S FREE FLY STORIES

11:30
01/22/18
01/22
11:30
01/22/18
11:30
General news
Bitcoin is back in the dog house slumping 10% »

Bitcoin is back in the…

KMB

Kimberly-Clark

$116.09

0.6 (0.52%)

11:26
01/22/18
01/22
11:26
01/22/18
11:26
Technical Analysis
Technical Earnings Preview: Kimberly-Clark in downtrend before news »

The stock has been in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$102.65

0.93 (0.91%)

, JUNO

Juno Therapeutics

$67.81

-3.56 (-4.99%)

11:25
01/22/18
01/22
11:25
01/22/18
11:25
Recommendations
Celgene, Juno Therapeutics, Gilead analyst commentary  »

Celgene, Juno deal…

CELG

Celgene

$102.65

0.93 (0.91%)

JUNO

Juno Therapeutics

$67.81

-3.56 (-4.99%)

GILD

Gilead

$80.98

-0.19 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 25

    Jan

  • 25

    Jan

  • 12

    Feb

  • 16

    Feb

  • 25

    Mar

MOS

Mosaic

$26.40

-0.135 (-0.51%)

11:25
01/22/18
01/22
11:25
01/22/18
11:25
Options
Mosaic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

LRAD

LRAD Corporation

$2.28

0.02 (0.88%)

11:25
01/22/18
01/22
11:25
01/22/18
11:25
Conference/Events
LRAD Corporation to ho ld a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

11:25
01/22/18
01/22
11:25
01/22/18
11:25
Conference/Events
Board of Governors of the Federal Reserve System holds a closed meeting »

The Board of Governors of…

MCO

Moody's

$158.72

-0.46 (-0.29%)

11:25
01/22/18
01/22
11:25
01/22/18
11:25
Conference/Events
Moody's management to meet with RBC Capital »

RBC Capital Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 09

    Feb

$NSD

NASDAQ Market Internals

11:17
01/22/18
01/22
11:17
01/22/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$91.66

0.59 (0.65%)

11:16
01/22/18
01/22
11:16
01/22/18
11:16
Technical Analysis
Technical Earnings Preview: Procter & Gamble near life highs before news »

The stock is not far from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 16

    Feb

$NYE

NYSE Market Internals

11:16
01/22/18
01/22
11:16
01/22/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLR

Continental Resources

$55.80

0.63 (1.14%)

11:15
01/22/18
01/22
11:15
01/22/18
11:15
Options
Continental Resources put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
01/22/18
01/22
11:15
01/22/18
11:15
General news
Treasury announced a $35 B 4-week bill offering for Tuesday »

Treasury announced a $35…

11:15
01/22/18
01/22
11:15
01/22/18
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

11:15
01/22/18
01/22
11:15
01/22/18
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

LQ

La Quinta

$20.32

0.135 (0.67%)

, WYN

Wyndham

$126.65

-0.34 (-0.27%)

11:13
01/22/18
01/22
11:13
01/22/18
11:13
Downgrade
La Quinta, Wyndham rating change  »

La Quinta downgraded to…

LQ

La Quinta

$20.32

0.135 (0.67%)

WYN

Wyndham

$126.65

-0.34 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

11:10
01/22/18
01/22
11:10
01/22/18
11:10
Periodicals
KGI's Kuo says Apple will discontinue first-generation iPhone X, MacRumors says »

Apple will discontinue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

11:04
01/22/18
01/22
11:04
01/22/18
11:04
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

ZIOP

Ziopharm

$4.28

-0.08 (-1.83%)

11:02
01/22/18
01/22
11:02
01/22/18
11:02
Periodicals
Ziopharm rise due to 'stupid money' inflow, Feuerstein says »

Adam Feuerstein tweeted:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LQ

La Quinta

$20.35

0.17 (0.84%)

11:02
01/22/18
01/22
11:02
01/22/18
11:02
Downgrade
La Quinta rating change  »

La Quinta downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWBI

Northwest Bancshares

$17.09

0.24 (1.42%)

11:01
01/22/18
01/22
11:01
01/22/18
11:01
Earnings
Northwest Bancshares reports Q4 EPS 22c, consensus 22c »

The company also…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKS

AK Steel

$6.10

-0.34 (-5.28%)

11:01
01/22/18
01/22
11:01
01/22/18
11:01
Hot Stocks
AK Steel: Ladle at Middletown Works caster malfunctioned, no injuries reported »

AK Steel said that on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

XLU

Utilities SPDR

$50.47

0.48 (0.96%)

11:00
01/22/18
01/22
11:00
01/22/18
11:00
Options
Renewed interest in SPDR Utility Fund Mar 49 puts »

Renewed interest in SPDR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWBI

Northwest Bancshares

$17.09

0.24 (1.42%)

10:59
01/22/18
01/22
10:59
01/22/18
10:59
Hot Stocks
Northwest Bancshares boosts quarterly dividend 6.25% to 17c per share »

The company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCS

Barclays

$11.61

0.4715 (4.23%)

10:56
01/22/18
01/22
10:56
01/22/18
10:56
Hot Stocks
Barclays: Nehren as head of statistical modeling & development, Equities »

Barclays announces the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGN

Align Technology

$269.46

-1.24 (-0.46%)

10:55
01/22/18
01/22
10:55
01/22/18
10:55
Options
Align Technology put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.